I received the following email dated 1.31.08 from Ian Musgrave:
Dear Dr. Dembski
Determining where a genome has been produced or altered by an intelligent designer is a matter of some importance. Consider the
claims that the HIV virus was engineered as a biowarfare weapon, or the concern that virulence genes from other organisms could be inserted into viruses and bacteria to “weaponise” them. For example the engineered mouse pox virus that turned lethal (Nature. 2001 May 17;411(6835):232-5 see also Nat Genet. 2001 Nov;29(3):253-6) and limits on the sequencing of the 1918 strain of the flu to stop flu from being weaponised (Fed Regist. 2005 Oct 20;70(202):61047-9,). A method that could reliably detect the action of human intelligent design in the genomes of microorganisms would be of significant advantage.Thus we issue the “Intelligent Design Challenge”. Below are 6 gene sequences. At least one of them has been produced by a human designer. All you have to do is to determine which one(s) have been acted on, what the designed sequence does, and explain the method you used to determine this (in sufficient detail to replicate your determination eg. if you used an approximation of Chaitin information, a brief description of the algorithm you used [not the entire program]). Given your interest in design, you may wish to participate. You migght also like to pass this on to your colleagues.
The first successful determination of the designed sequence(s) and their function will win a copy of OpenLab 2007, the best of Science Blogging. You may wish to Reminding everyone again, the comments will be opened at 10:30 pm Australian Central Daylight Savinng Time (GMT +10:30), 1 February.
Sequence 1:
attatcacaa aatggtgtga tcttatcaat
agcactactt gcttaactag ctaatgtcgt
gcaattggag tagagaacac agaacgatta
actagctaat ttttttagtt ggatggcaat
tgttggaatt cacagctttt tagttggaat
tttagttaat catcaaacac ttaaaataag
taaaaagtat gttattttag gttcgatttt
tccaattatg gcattaacaa atactcttgtSequence 2:
gatagtagtg ggtggaatag tgaagaaaac
gaagctaaaa gtgatgcgcc cctaagtaca
ggagggggtg cttcttctgg aacatttaat
aaatacctca acaccaagca agcgttagag
agcatcggca tcttgtttga tggggatgga
atgaggaatg tggttaccca actctattat
gcttctacca gcaagctagc agtcaccaac
aaccacattg tcgtgatggg taacagctttSequence 3:
attatcacaa aatggtgtga tcttatcaat
agcactactt gcttttttta gttggatggc
aattgttgga attcacagct ttttagttgg
aattttagtt aatcatcaaa cacttaaaat
aagtaaaaag tatgttattt taggttcgat
ttttccaatt atggcattaa caaatactct
tgtaattaga aaaaaattaa aagctttatt
aggagagggt aaggttcaaa aaggactcaaSequence 4:
agtagtgggt ggaatagtgt taactagcta
agtagaaaac accgaacgaa ttaattctac
gattaccgtg actgagttaa ctagctaaaa
gaaaacgaag ctaaaagtga tgcgccccta
agtacaggag ggggtgcttc ttctggaaca
tttaataaat acctcaacac caagcaagcg
ttagagagca tcggcatctt gtttgatggg
gatggaatga ggaatgtggt tacccaactcSequence 5:
ttttatttgt ttaatagtta aaaaaagcgt
taactagcta atgcataaac gacatcgcta
atgactgtct ttatgatgaa ttaactagct
aatgggtcga tgtttgatgt tatggagcag
caacgatgtt acgcagcagg gcagtcgccc
taaaacaaag ttaaacatca tgttatgttt
tatctatttt attagttaaa aaagttttga
atttttatct atttttagtt aataaaagtcSequence 6:
ggagggagat catcagatca aagtaataaa
ttcaccaagt acctcaacac caagcaagca
ttggaaagga tcggcatctt gtttgatggg
gatggaatga ggaatgtggt tacccaactc
taccaaccca acaaggtgaa aagtggtcaa
tatcaacaaa ataacaccta caacaggtta
attgagcctg acaatgcaac aagtgcagcg
agcagcatga ccagcttgtt aaagctgttgYours sincerely
Ian Musgrave========================================
Ian F. Musgrave Ph.D, ian.musgrave@adelaide.edu.au
Senior Lecturer, Discipline of Pharmacology, School of Medical Sciences
Co-convener, Healthy Aging Research Cluster
University of Adelaide, SA, 5005, Australia